Showing results (191-200 of 219) with videos related to
Sort By:
Pageof 22
American Journal of Human Genetics|March 16, 2007
Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levelsDavid Reich, Nick Patterson, Vijaya Ramesh, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomasSam S Yoon, Dan G Duda, Daniel L Karl, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2021
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I TrialIngo K Mellinghoff, Marta Penas-Prado, Katherine B Peters, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue SarcomaChristopher W Ryan, Ofer Merimsky, Mark Agulnik, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2021
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1Sant P Chawla, Brian A Van Tine, Seth M Pollack, et al.Cancer|October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumorScott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid HemangioendotheliomaScott M Schuetze, Karla V Ballman, Rachel Heise, et al.Nature Medicine|June 5, 2023
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial resultsTimothy A Yap, Elisa Fontana, Elizabeth K Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCTWilliam D Tap, Arun S Singh, Stephen Patrick Anthony, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response (DDR) Aberrations: Preclinical and Phase 1b ResultsEzra Y Rosen, Timothy A Yap, Elisa Fontana, et al.Pageof 22